Skip to main content
Top
Published in: Journal of Clinical Immunology 3/2015

01-04-2015 | Original Research

The Duesseldorf Warning Signs for Primary Immunodeficiency: Is it Time to Change the Rules?

Authors: Petra Lankisch, Julia Schiffner, Sujal Ghosh, Florian Babor, Arndt Borkhardt, Hans-Jürgen Laws

Published in: Journal of Clinical Immunology | Issue 3/2015

Login to get access

Abstract

Objective

Different sets of warning signs can be used if primary immunodeficiency (PID) is suspected: those of the Jeffrey Modell Foundation (JMF), the German Patients’ Organisation for Primary Immunodeficiencies (DSAI) and the Association of the Scientific Medical Societies in Germany (AWMF). A few studies have tested the JMF criteria, with unconvincing results, but the diagnostic models of the DSAI and AWMF have not been tested at all. We set out to establish the utility of these three scoring systems and compare them with our own set of five warning signs (Duesseldorf criteria).

Design

Prospective study.

Patients

Two hundred ten patients admitted to our hospital between 2010 and 2012 with suspected PID.

Results

PID were found in 36 (17 %) of the patients admitted. Of the established sets of warning signs, the JMF and the DSAI had inadequate sensitivity, while the DSAI and the AWMF showed insufficient specificity. Our own criteria were analyzed with regard to maximal specificity and sensitivity (Youden Index) and sensitivity and yielded NPV of 0.89 and 0.91 respectively. Youden index revealed combination of five signs and symptoms: lymphopenia, otitis media >7, failure to thrive, failure to grow normally, pneumonia >1. For maximum negative predictive value the following set was found: lymphopenia, hypogammglobulinemia, failure to thrive, growth disorders, iv antibiotics and abscesses.

Conclusion

In contrast to the new, evaluated Duesseldorf criteria, all three established sets of warning signs proved inadequate for preselection of patients for admission to specialized PID centers. The Duesseldorf criteria should now being tested in further studies.
Literature
1.
go back to reference Gathmann B, Grimbacher B, Beaute J, Dudoit Y, Mahlaoui N, Fischer A, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157 Suppl 1:3–11.CrossRefPubMedCentralPubMed Gathmann B, Grimbacher B, Beaute J, Dudoit Y, Mahlaoui N, Fischer A, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157 Suppl 1:3–11.CrossRefPubMedCentralPubMed
2.
go back to reference Al-Tamemi S, Elnour I, Dennison D. Primary immunodeficiency diseases in Oman: five years’ experience at sultan qaboos university hospital. World Allergy Organ J. 2012;5(5):52–6.CrossRefPubMedCentralPubMed Al-Tamemi S, Elnour I, Dennison D. Primary immunodeficiency diseases in Oman: five years’ experience at sultan qaboos university hospital. World Allergy Organ J. 2012;5(5):52–6.CrossRefPubMedCentralPubMed
3.
go back to reference Ehlayel MS, Bener A, Laban MA. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar. J Clin Immunol. 2013;33(2):317–24.CrossRefPubMed Ehlayel MS, Bener A, Laban MA. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar. J Clin Immunol. 2013;33(2):317–24.CrossRefPubMed
4.
go back to reference Arkwright PD, Gennery AR. Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Ann N Y Acad Sci. 2011;1238:7–14.CrossRefPubMed Arkwright PD, Gennery AR. Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Ann N Y Acad Sci. 2011;1238:7–14.CrossRefPubMed
5.
go back to reference Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497–502.CrossRefPubMed Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497–502.CrossRefPubMed
6.
go back to reference Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33(1):1–7.CrossRefPubMed Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33(1):1–7.CrossRefPubMed
8.
go back to reference Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc Mayo Clin. 2009;84(1):16–22.CrossRef Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc Mayo Clin. 2009;84(1):16–22.CrossRef
9.
go back to reference Mohammadinejad P, Mirminachi B, Sadeghi B, Movahedi M, Gharagozlou M, Mohammadi J, et al. Distribution of primary immunodeficiency disorders diagnosed in a tertiary referral center, Tehran, Iran (2006–2013). Iran J Immunol IJI. 2014;11(4):282–91. Mohammadinejad P, Mirminachi B, Sadeghi B, Movahedi M, Gharagozlou M, Mohammadi J, et al. Distribution of primary immunodeficiency disorders diagnosed in a tertiary referral center, Tehran, Iran (2006–2013). Iran J Immunol IJI. 2014;11(4):282–91.
10.
go back to reference Michos A, Raptaki M, Tantou S, Tzanoudaki M, Spanou K, Liatsis M, et al. Primary immunodeficiency diseases: a 30-year patient registry from the referral center for primary immunodeficiencies in Greece. J Clin Immunol. 2014;34(7):836–43.CrossRefPubMed Michos A, Raptaki M, Tantou S, Tzanoudaki M, Spanou K, Liatsis M, et al. Primary immunodeficiency diseases: a 30-year patient registry from the referral center for primary immunodeficiencies in Greece. J Clin Immunol. 2014;34(7):836–43.CrossRefPubMed
11.
go back to reference Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, et al. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013;173(2):372–80.CrossRefPubMedCentralPubMed Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, et al. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013;173(2):372–80.CrossRefPubMedCentralPubMed
12.
go back to reference Wood P, Stanworth S, Burton J, Jones A, Peckham DG, Green T, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol. 2007;149(3):410–23.CrossRefPubMedCentralPubMed Wood P, Stanworth S, Burton J, Jones A, Peckham DG, Green T, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol. 2007;149(3):410–23.CrossRefPubMedCentralPubMed
13.
go back to reference Carneiro-Sampaio M, Jacob CM, Leone CR. A proposal of warning signs for primary immunodeficiencies in the first year of life. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2011;22(3):345–6.CrossRef Carneiro-Sampaio M, Jacob CM, Leone CR. A proposal of warning signs for primary immunodeficiencies in the first year of life. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2011;22(3):345–6.CrossRef
16.
go back to reference Farmand S, Baumann U, von Bernuth H, Borte M, Foerster-Waldl E, Franke K, et al. Interdisciplinary AWMF guideline for the diagnostics of primary immunodeficiency. Klin Padiatr. 2011;223(6):378–85.CrossRefPubMed Farmand S, Baumann U, von Bernuth H, Borte M, Foerster-Waldl E, Franke K, et al. Interdisciplinary AWMF guideline for the diagnostics of primary immunodeficiency. Klin Padiatr. 2011;223(6):378–85.CrossRefPubMed
17.
go back to reference MacGinnitie A, Aloi F, Mishra S. Clinical characteristics of pediatric patients evaluated for primary immunodeficiency. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2011;22(7):671–5.CrossRef MacGinnitie A, Aloi F, Mishra S. Clinical characteristics of pediatric patients evaluated for primary immunodeficiency. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2011;22(7):671–5.CrossRef
18.
go back to reference Subbarayan A, Colarusso G, Hughes SM, Gennery AR, Slatter M, Cant AJ, et al. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics. 2011;127(5):810–6.CrossRefPubMed Subbarayan A, Colarusso G, Hughes SM, Gennery AR, Slatter M, Cant AJ, et al. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics. 2011;127(5):810–6.CrossRefPubMed
19.
go back to reference Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2014;5:162.PubMedCentralPubMed Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2014;5:162.PubMedCentralPubMed
20.
go back to reference Lankisch P, Borkhardt A, Pfründer D, Laws H-J. What lies behind the referral diagnosis “e.g. an immune defect?”. Monatsschr Kinderheilkd. 2014;162:146–9.CrossRef Lankisch P, Borkhardt A, Pfründer D, Laws H-J. What lies behind the referral diagnosis “e.g. an immune defect?”. Monatsschr Kinderheilkd. 2014;162:146–9.CrossRef
21.
go back to reference Moskowitz CS, Pepe MS. Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs. Clin Trials. 2006;3(3):272–9.CrossRefPubMed Moskowitz CS, Pepe MS. Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs. Clin Trials. 2006;3(3):272–9.CrossRefPubMed
22.
go back to reference Bloch DA. Comparing two diagnostic tests against the same “gold standard” in the same sample. Biometrics. 1997;53(1):73–85.CrossRefPubMed Bloch DA. Comparing two diagnostic tests against the same “gold standard” in the same sample. Biometrics. 1997;53(1):73–85.CrossRefPubMed
23.
go back to reference Reda SM, El-Ghoneimy DH, Afifi HM. Clinical predictors of primary immunodeficiency diseases in children. Allergy Asthma Immunol Res. 2013;5(2):88–95.CrossRefPubMedCentralPubMed Reda SM, El-Ghoneimy DH, Afifi HM. Clinical predictors of primary immunodeficiency diseases in children. Allergy Asthma Immunol Res. 2013;5(2):88–95.CrossRefPubMedCentralPubMed
Metadata
Title
The Duesseldorf Warning Signs for Primary Immunodeficiency: Is it Time to Change the Rules?
Authors
Petra Lankisch
Julia Schiffner
Sujal Ghosh
Florian Babor
Arndt Borkhardt
Hans-Jürgen Laws
Publication date
01-04-2015
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 3/2015
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-015-0149-1

Other articles of this Issue 3/2015

Journal of Clinical Immunology 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.